|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 18, 2016 ) The report “Aptamers Market by Type (DNA, RNA, XNA), by Application (Diagnostics, Therapeutics, R&D), by Technology (SELEX, Other Technologies), by End Users (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, CRO) - Global Forecast to 2020”. The global aptamers market is expected to reach $244.93 Million by 2020 from $107.56 Million in 2015, at a CAGR of 17.89%.
Browse 74 market tables and 67 figures spread through 125 pages and an in-depth TOC on “Aptamers Market by Type (DNA, RNA, XNA), by Application (Diagnostics, Therapeutics, R&D), by Technology (SELEX, Other Technologies), by End Users (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, CRO) - Global Forecast to 2020”
<||>rnhttp://www.marketsandmarkets.com/Market-Reports/aptamers-technology-market-1167.html
Early buyers will receive 10% customization on reports.
The report provides a detailed overview of the major drivers, restraints, and opportunities impacting the global aptamers market along with the estimates and forecasts of the revenue and market share analysis.
The global aptamers market is poised for rapid growth between 2015 and 2020. Factors such as strong trend of R&D investments in biotechnology and pharmaceutical industries, the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies are driving the growth of the aptamers market.
The aptamers market is segmented on the basis of type, application, technology, and end user. By type, the market includes DNA-based aptamers, RNA-based aptamers, and XNA-based aptamers. DNA-based aptamers will hold the largest share of the aptamers market in 2015, while XNA-based aptamers will grow at the highest CAGR between 2015 and 2020.
The applications included in this report are diagnostics, therapeutics development, research and development, and others. The diagnostics application segment will hold largest share of the aptamers market in 2015. Therapeutics development is expected to be one of the fastest-growing applications between 2015 and 2020.
The technologies included in this report are SELEX and other technologies. SELEX will hold the largest share of the aptamers market in 2015. The other technologies segment is expected to grow at the highest rate between 2015 and 2020.
The end users included in this report are academic and government research institutes, biotechnology and pharmaceutical companies, contract research organizations (CROs), and other end users. Of these, the academic and government research institutes will hold the largest share of the aptamers market in 2015. The biotechnology and pharmaceutical companies are expected to be the fastest-growing end-user segment between 2015 and 2020.
The geographic segments included in this report are the Americas, Europe, Asia, and the Rest of the World (RoW). The Americas are expected to hold the largest share of this market in 2015, while Europe is expected to grow at the fastest rate. Growth in the European aptamers market will primarily be driven by the increased number of aptamer manufacturers in this region.
Major players in the global aptamers market are AM Biotechnologies, LLC (U.S.), Aptagen, LLC (U.S.), Aptamer Sciences, Inc. (South Korea), Aptamer Solutions Ltd. (U.K.), Aptus Biotech S.L. (Spain), Base Pair Biotechnologies, Inc. (U.S.), NeoVentures Biotechnology, Inc. (Canada), SomaLogic, Inc. (U.S.), TriLink BioTechnologies, Inc. (U.S.), and Vivonics, Inc. (U.S.).
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
